MORGAN STANLEY PLC/CALL/MERCK & CO./145/0.1/21.03.25 Share Price

Warrant

DE000MB745Q0

Real-time Bid/Ask 05:46:21 08/07/2024 pm IST
0.33 EUR / 0.35 EUR +9.68% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./145/0.1/21.03.25
Current month-34.04%
1 month-27.91%
Date Price Change
08/24/08 0.32 +3.23%
05/24/05 0.31 +6.90%
04/24/04 0.29 -9.38%
03/24/03 0.32 -15.79%
02/24/02 0.38 -2.56%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 01:43 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB745Q
ISINDE000MB745Q0
Date issued 07/06/2023
Strike 145 $
Maturity 21/03/2025 (256 Days)
Parity 10 : 1
Emission price 0.51
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.69
Lowest since issue 0.083
Delta0.28x
Omega 9.728
Premium17.58x
Gearing34.31x
Moneyness 0.8721
Difference Strike 17.67 $
Difference Strike %+12.18%
Spread 0.02
Spread %5.71%
Theoretical value 0.3400
Implied Volatility 21.47 %
Total Loss Probability 76.95 %
Intrinsic value 0.000000
Present value 0.3400
Break even 148.69 €
Theta-0.01x
Vega0.03x
Rho0.02x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus